Advertisement

Topics

CAR T Cells Bring Promise to Patients With ALL, DLBCL With Poor Prognosis

09:51 EDT 26 Mar 2019 | OncLive

Lazaros J. Lekakis, MD, discusses the promise of CAR T cells and some unanswered questions with this rapidly emerging therapy.

Original Article: CAR T Cells Bring Promise to Patients With ALL, DLBCL With Poor Prognosis

NEXT ARTICLE

More From BioPortfolio on "CAR T Cells Bring Promise to Patients With ALL, DLBCL With Poor Prognosis"

Advertisement
Quick Search
Advertisement
Advertisement